CRVO Stock Analysis: Buy, Sell, or Hold?
CRVO - CervoMed Inc. Common Stock
$2.65
0.00 (0.00%)
â˛
5d:
-2.21%
30d:
+3.52%
90d:
-12.83%
WAIT
LOW Confidence
Analysis Updated: Aug 26, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When CRVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CRVO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CRVO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CRVO is currently trading at $2.65, which is considered fair relative to its 30-day fair value range of $2.57 to $2.87.
Technical Outlook: Technically, CRVO is in a strong downtrend. Immediate support is located at $2.50, while resistance sits at $3.19.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.40 (+481.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRVO is in a strong downtrend. Immediate support is located at $2.50, while resistance sits at $3.19.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.40 (+481.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.57 -
$2.87
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 481.1% below Wall St target ($15.40)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.57 -
$2.87
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$3.19
Current Trend
Strong Downtrend
Technical data as of
Aug 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.80
Wall Street Target
$15.40
(+481.1%)
Revenue Growth (YoY)
-99.6%
Share & Embed Analysis
Last updated: August 26, 2026 10:28 PM ET
Data refreshes hourly during market hours. Next update: 11:28 PM
Data refreshes hourly during market hours. Next update: 11:28 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 48 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 35 SELL |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 55 HOLD |
